The present invention relates to a composition comprising a mixed alcoholic extract of eighteen botanical ingredients formulated into capsules for the treatment of H1N1 flu, strep, pneumonia, and Covid-19.

The present invention relates to a composition comprising a mixed alcoholic extract of eighteen botanical ingredients formulated into capsules for the treatment of H1N1 flu, strep, pneumonia, and Covid-19.

The present invention relates to a composition comprising a mixed alcoholic extract of eighteen botanical ingredients formulated into capsules for the treatment of H1N1 flu, strep, pneumonia, and Covid-19.

A method for producing black ginseng concentrate is characterized by including steps of adding red ginseng to a continuous steaming-dryer followed by steaming, cooling, and drying to prepare black ginseng, carrying out extraction by adding alcohol to crushed black ginseng obtained by crushing the black ginseng prepared above followed by filtration to prepare black ginseng extract, and concentrating the black ginseng extract prepared above by using a plate type evaporative concentrator followed by heat treatment, and the present invention also relates to black ginseng concentrate prepared by the aforementioned method.

A method for producing black ginseng concentrate is characterized by including steps of adding red ginseng to a continuous steaming-dryer followed by steaming, cooling, and drying to prepare black ginseng, carrying out extraction by adding alcohol to crushed black ginseng obtained by crushing the black ginseng prepared above followed by filtration to prepare black ginseng extract, and concentrating the black ginseng extract prepared above by using a plate type evaporative concentrator followed by heat treatment, and the present invention also relates to black ginseng concentrate prepared by the aforementioned method.

Disclosed herein are compositions comprising a citrus peel composition, a phosphate composition, or a combination of both. The compositions disclosed herein may additionally comprise bee pollen, horsetail herb, cabbage powder, curcumin, epigallocatechin gallate, resveratrol, pterostilbene, niacin, NAD+ precursors, L-theanine, coenzyme Q10, coenzyme Q9, omega-3-fatty acids, phytophenols, flavonoids, ascorbic acid, folate, and stevia. The description herein describes methods for synergistically treating or ameliorating scoliosis, among other conditions or diseases. The compositions described herein may be formulated for oral, sublingual, dental, or intragingival delivery.

Disclosed herein are compositions comprising a citrus peel composition, a phosphate composition, or a combination of both. The compositions disclosed herein may additionally comprise bee pollen, horsetail herb, cabbage powder, curcumin, epigallocatechin gallate, resveratrol, pterostilbene, niacin, NAD+ precursors, L-theanine, coenzyme Q10, coenzyme Q9, omega-3-fatty acids, phytophenols, flavonoids, ascorbic acid, folate, and stevia. The description herein describes methods for synergistically treating or ameliorating scoliosis, among other conditions or diseases. The compositions described herein may be formulated for oral, sublingual, dental, or intragingival delivery.

The invention is a cosmetic or dermatological preparation and the use thereof, said preparation comprising a combination of a) glycoprotein 1, b) glycoprotein 2, ginseng extract and d) equisetum extract, to protect the skin against extrinsic skin aging.

The invention is a cosmetic or dermatological preparation and the use thereof, said preparation comprising a combination of a) glycoprotein 1, b) glycoprotein 2, ginseng extract and d) equisetum extract, to protect the skin against extrinsic skin aging.

The invention is a cosmetic or dermatological preparation and the use thereof, said preparation comprising a combination of a) glycoprotein 1, b) glycoprotein 2, ginseng extract and d) equisetum extract, to protect the skin against extrinsic skin aging.